| Expression pattern: |
UP |
| Associated gene: |
KDM1A, Ago2 |
| Associated microRNA: |
miR-27b-3p |
| Biological function: |
promotes proliferation, migration and invasion; inhibits apoptosis; promotes tumor formation in vivo |
| Molecular mechanism: |
Acts as a miRNA sponge for miR-27b-3p to de-repress KDM1A (ceRNA-like regulation); associated with Ago2 complex |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Nuclear-Cytoplasmic Fractionation; Actinomycin D / DRB Stability Assay; Dual-luciferase reporter assay; RIP (RNA Immunoprecipitation); RNA Pull-Down; Transfection; MTT; EdU Staining; Colony Formation Assay; Wound Healing Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); Clinical Sample Validation |
| Clinical significance: |
- |
| Description: |
circRANBP17 is up-regulated in neuroblastoma tissues/cells and mainly localized in the cytoplasm. It promotes NB malignant behaviors (proliferation, migration, invasion, tumor growth) and inhibits apoptosis by sponging miR-27b-3p to increase KDM1A expression. |
| Confidence score: |
0.8201 |